Valneva has been awarded $41m in funding from the CEPI and EU to expand access to its recently approved Ixchiq vaccine for chikungunya virus.

The EMA's human medicines committee has recommended approval for Bavarian Nordic's chikungunya vaccine, which is shaping up to be the first alternative to a rival shot from Valneva. The CHIKV VLP ...

ilustrasi(freepik) DEMAM berdarah dengue menjadi ancaman sepanjang tahun.Sebagai negara endemis, dengue bukan penyakit musiman. Dengue masih menjadi tantangan besar dalam sistem kesehatan Indonesia.

Stay up-to-date on APA Corporation Common Stock (APA) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule.